Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How many protein pairs can we chemically target?

Drug discovery today·2026
Same author

Novel drug targets in 2025.

Nature reviews. Drug discovery·2026
Same author

Target identification and assessment in the era of AI.

Nature reviews. Drug discovery·2026
Same author

The Common Fund Data Ecosystem (CFDE).

bioRxiv : the preprint server for biology·2026
Same author

CACHE Challenge #3: Targeting the Nsp3 Macrodomain of SARS-CoV-2.

Journal of chemical information and modeling·2026
Same author

Medicines, Diseases, Indications, and Contraindications (MeDIC): a foundational resource to support drug repurposing.

Nucleic acids research·2025

Related Experiment Video

Updated: Jul 11, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Ligand-based virtual screening by novelty detection with self-organizing maps.

Dimitar Hristozov1, Tudor I Oprea, Johann Gasteiger

  • 1Computer-Chemie-Centrum, Universität Erlangen-Nürnberg, Nägelsbachstrasse 25, Erlangen, Germany.

Journal of Chemical Information and Modeling
|September 15, 2007
PubMed
Summary

This study introduces a novel method for virtual screening using Self-Organizing Maps (SOM) for novelty detection. This approach effectively identifies potentially active compounds without needing inactive ones, improving drug discovery efficiency.

More Related Videos

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jul 11, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules
08:43

A Fluorescence-based Lymphocyte Assay Suitable for High-throughput Screening of Small Molecules

Published on: March 10, 2017

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Area of Science:

  • Computational Chemistry
  • Cheminformatics
  • Drug Discovery

Background:

  • Ligand-based virtual screening aims to identify novel bioactive compounds.
  • Existing methods often require known inactive compounds, which are scarce in databases.
  • Novelty detection offers a way to identify compounds outside the known activity space.

Purpose of the Study:

  • To present a novel ligand-based virtual screening method using Self-Organizing Maps (SOM) for novelty detection.
  • To address the limitation of scarce inactive compounds in virtual screening.
  • To evaluate the performance of SOM-based novelty detection against traditional similarity searches.

Main Methods:

  • Utilized Self-Organizing Maps (SOM) as a novelty detection tool for virtual screening.
  • Represented chemical structures using spatial autocorrelation functions weighted by atomic physicochemical properties.
  • Compared SOM-based novelty detection with similarity searches using Daylight fingerprints and data fusion.

Main Results:

  • SOM-based novelty detection achieved significant enrichment factors (105-462) in retrospective screening.
  • This method demonstrated a 25%-100% improvement over Daylight fingerprint similarity searches for top-ranked compounds.
  • The two methods, novelty detection and similarity search, were found to be complementary.

Conclusions:

  • Novelty detection with SOM is a valuable tool for improving the retrieval of potentially active compounds.
  • It can be used in conjunction with other virtual screening methods.
  • SOM-based novelty detection serves as an effective library design tool and for selecting promising compounds from large datasets.